CXCL10 and melanoma: The mechanisms at the basis of these effects may include the production of CXCL10, a chemokine recognized for its role in the recruitment of tumor-infiltrating lymphocytes being required for antitumor immune responses following immune checkpoint blockade (House et al, 2020) and acting as a biomarker for long-term survival of melanoma patients (Kaesler et al, 2019).